LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.73
-0.02 (-2.67%)
Open$0.73
Previous Close$0.75
Day High$0.73
Day Low$0.70
52W High$37.50
52W Low—
Volume—
Avg Volume9.8K
Market Cap1.33M
P/E Ratio—
EPS$-23.78
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,817.8% upside
Current
$0.73
$0.73
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.12M | 1.22M | 681.7K |
| Net Income | -129,081,057 | -66,674,099 | 169.3K |
| Profit Margin | -6,090.9% | -5,786.4% | 24.8% |
| EBITDA | -132,454,747 | -72,217,636 | 337.6K |
| Free Cash Flow | — | — | 110.0K |
| Rev Growth | +74.2% | +74.2% | +3.7% |
| Debt/Equity | — | — | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |